Carl June

Type: Person
Name: Carl June
First reported 4 hours ago - Updated 26 mins ago - 1 reports

Ziopharm Joins The CAR Crowd

Summary Ziopharm recently announced they have a chimeric antigen receptor program utilizing Intrexon's rheoswitch technology. The kinetics of the rheoswitch do not appear to be compatible with the needs of physicians who administer CAR T cell therapy. ... [Published Seeking Alpha - 4 hours ago]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Personalised cellular therapy for leukemia receives breakthrough therapy designation

A University of Pennsylvania-developed personalised immunotherapy has been awarded the FDA's breakthrough therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL). The investigational therapy, ... [Published European Pharmaceutical Manufacturer - Jul 23 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

University of Pennsylvania's Personalized Cellular Therapy for Leukemia Receives FDA's Breakthrough Therapy Designation

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A University of Pennsylvania -developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed ... [Published 4 Traders - Jul 16 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Novartis receives fifth Breakthrough Therapy designation with CTL019 for leukemia

Swiss drug major Novartis (NOVN: VX) has been granted Breakthrough Therapy designation for its leukemia treatment CTL019 from the US Food and Drug Administration.The drug is an investigational chimeric antigen receptor and can be used in the treatment ... [Published Pharma Letter - Jul 08 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

U.S. regulators fast-track novel leukemia therapy

WASHINGTON – U.S. regulators on Monday put an experimental immunotherapy agent on the fast track to market approval, after 89 percent of leukemia patients in early trials saw their cancers disappear.The personalized immunotherapy known as CTL019 was developed ... [Published Japan Times - Jul 07 2014]
First reported Jul 07 2014 - Updated Jul 07 2014 - 1 reports

University of Pennsylvania's Personalized Cellular Therapy for Leukemia Receives FDA's Breakthrough Therapy Designation

/PRNewswire/ -- A University of Pennsylvania -developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic ... [Published Good Day Sacramento - Jul 07 2014]
First reported Jun 26 2014 - Updated Jun 26 2014 - 1 reports

Lexington grad's ride marks 30 cancer-free years

MANSFIELD — Lexington graduate John Robinson was 14 when he was diagnosed with acute lymphocytic leukemia and told he had only a 35 percent chance of survival.A persistent nosebleed during summer camp in 1984 had alerted doctors.He went through the usual ... [Published Mansfield News Journal - Jun 26 2014]
First reported Jun 09 2014 - Updated Jun 10 2014 - 1 reports

Immunotherapies: The New Hope for Cancer Treatment

Ben ComerDespite a steady stream of new, highly-targeted cancer therapies entering the market in recent years, most patients strugglingagainst the disease aren't living much longer. In terms of disease progression and death, health outcomes in oncology ... [Published Pharmaceutical Executive - Jun 09 2014]
First reported Jun 04 2014 - Updated Jun 04 2014 - 1 reports

Leukemia researcher tapped for 2014 Taubman Prize

ANN ARBOR, Mich.Carl JuneThe research is considered a landmark breakthrough in treating blood cancers that have stopped responding to conventional therapies, or for patients who are not candidates for bone marrow transplants, which carry a high mortality ... [Published PR Newswire - Jun 04 2014]
First reported Jun 03 2014 - Updated Jun 04 2014 - 1 reports

Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD

<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=WcnzetT4ezY&feature=youtube_gdata"&gt;Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD Visit: http://www.uctv.tv/) ... [Published UC Television - YouTube - Jun 03 2014]
First reported May 17 2014 - Updated May 17 2014 - 1 reports

Dr. Carl June: "Putting the Immune System on Steroids"

A professor of immunology at the University of Pennsylvania’s Perelman School of Medicine, Dr. Carl June gave a captivating description of the promise of immunology therapy during a presentation Wednesday, May 14 at UC San Diego. For Dr. Carl June, lead ... [Published PRWeb - May 17 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

What's the Latest in Cancer Therapy? Immunotherapy Research Leader Dr. Carl June to Speak at UC San Diego, May 14

Immunotherapy is one of the most exciting new approaches to treating cancer. Dr. Carl June will discuss his findings May 14 as featured speaker at UC San Diego. A world leader in immunotherapy, Carl June, will discuss the emergence of a new form of targeted ... [Published PRWeb - Apr 04 2014]

Quotes

...their normal lives at school and work after receiving this new, personalised immunotherapy," said the Penn research team's leader, Carl June, MD. "receiving the fda's breakthrough designation is an essential step in our work with novartis to expand this therapy to patients across the world who desperately need new options to help them fight this disease."

More Content

All (23) | News (16) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Ziopharm Joins The CAR Crowd [Published Seeking Alpha - 4 hours ago]
Personalised cellular therapy for leukemia rece... [Published European Pharmaceutical Manufacturer - Jul 23 2014]
University of Pennsylvania's Personalized Cellu... [Published 4 Traders - Jul 16 2014]
Novartis receives fifth Breakthrough Therapy de... [Published Pharma Letter - Jul 08 2014]
U.S. regulators fast-track novel leukemia therapy [Published Japan Times - Jul 07 2014]
University of Pennsylvania's Personalized Cellu... [Published Good Day Sacramento - Jul 07 2014]
Lexington grad's ride marks 30 cancer-free years [Published Mansfield News Journal - Jun 26 2014]
Immunotherapies: The New Hope for Cancer Treatment [Published Pharmaceutical Executive - Jun 09 2014]
Leukemia researcher tapped for 2014 Taubman Prize [Published PR Newswire - Jun 04 2014]
Immunotherapy: A Promising New Approach to Trea... [Published UC Television - YouTube - Jun 03 2014]
Dr. Carl June: "Putting the Immune System on St... [Published PRWeb - May 17 2014]
Bryn Mawr couple to be honored as recipients of... [Published Main Line Times - May 06 2014]
What's the Latest in Cancer Therapy? Immunother... [Published PRWeb - Apr 04 2014]
Genetically Engineered T Cells Used as a Weapon... [Published Lifeboat News The Blog - Mar 25 2014]
Genetically Engineered T Cells Used as a Weapon... [Published Singularity Hub - Mar 23 2014]
The search for a cure for AIDS: If it ain’t broke… [Published The Economist - Science & Technology - Mar 06 2014]
Treating HIV without drugs [Published AMERICAblog News| A great nation deserves the t ... - Mar 06 2014]
Gene therapy success raises hopes of 'cure' for... [Published The First Post: Latest - Mar 06 2014]
Gene-editing method tackles HIV in first clinic... [Published 3quarksdaily - Mar 06 2014]
Deals Of The Week: Novartis Places Bid To Domin... [Published The IN VIVO Blog - Feb 21 2014]
After Andrew Fox's death, his melanoma research... [Published Main Line Life - Nov 21 2013]
USP, ISCT to host workshop on âCell & Tissue-ba... [Published PharmaBiz - Nov 05 2013]
ACGT’s Top Researchers and Physicians Discuss t... [Published PRWeb - Oct 19 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Immunotherapy: A Promising New Approach to Trea... [Published UC Television - YouTube - Jun 03 2014]
<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=WcnzetT4ezY&feature=youtube_gdata"&gt;Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD Visit: http://www.uctv.tv/) ...
Genetically Engineered T Cells Used as a Weapon... [Published Lifeboat News The Blog - Mar 25 2014]
Cameron Scott — Singularity Hub Carl June and his colleagues at the University of Pennsylvania have been making waves since they published some successes fighting leukemia with a revolutionary new method. They removed patients’ T cells and genetically ...
Genetically Engineered T Cells Used as a Weapon... [Published Singularity Hub - Mar 23 2014]
Carl June and his colleagues at the University of Pennsylvania have been making waves since they published some successes fighting leukemia with a revolutionary new method. They removed patients’ T cells and genetically modified them to target and ...
The search for a cure for AIDS: If it ain’t broke… [Published The Economist - Science & Technology - Mar 06 2014]
To your very good health, sir!GENE therapy usually works by repairing a broken gene or creating a new one where none previously existed. Breaking a working gene to effect a cure is a novel approach. That, though, is what Carl June of the University ...
Treating HIV without drugs [Published AMERICAblog News| A great nation deserves the t ... - Mar 06 2014]
A new method for the treatment of HIV, without using drugs, This new approach was announced yesterday in a  paper published in the New England Journal of Medicine . Very early results look promising but, as with almost all new techniques, additional ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.